Ferrucci, P F
Gandini, S
Battaglia, A
Alfieri, S
Di Giacomo, A M
Giannarelli, D
Cappellini, G C Antonini
De Galitiis, F
Marchetti, P
Amato, G
Lazzeri, A
Pala, L
Cocorocchio, E
Martinoli, C
Article History
Revised: 2 April 2015
Accepted: 17 April 2015
First Online: 26 May 2015
Competing interests
: PFF has participated in advisory boards and expert panels for Bristol-Myers Squibb, Roche-Genentech and GlaxoSmithKline. AMDG has served as a speaker in Bristol-Myers Squibb, Roche-Genentech, and GlaxoSmithKline. PM has served as a consultant or in an advisory role for Bristol-Myers Squibb, Roche-Genentech, GlaxoSmithKline, Pfizer and Novartis. EC has served as a consultant for Bristol-Myers Squibb and GlaxoSmithKline. The remaining authors declare no conflict of interest.